These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28666971)

  • 81. Autoantibodies to osteoprotegerin are associated with increased bone resorption in rheumatoid arthritis.
    Hauser B; Riches PL; Gilchrist T; Visconti MR; Wilson JF; Ralston SH
    Ann Rheum Dis; 2015 Aug; 74(8):1631-2. PubMed ID: 25926154
    [No Abstract]   [Full Text] [Related]  

  • 82. Estrogen deficiency and bone loss: an inflammatory tale.
    Weitzmann MN; Pacifici R
    J Clin Invest; 2006 May; 116(5):1186-94. PubMed ID: 16670759
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Menopause and aging: changes in the immune system--a review.
    Gameiro CM; Romão F; Castelo-Branco C
    Maturitas; 2010 Dec; 67(4):316-20. PubMed ID: 20813470
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Menopause and Possible Effect on Association Between Age and Anticyclic Citrullinated Peptide Antibodies in Women At Risk of Rheumatoid Arthritis.
    Alpizar-Rodriguez D; Finckh A
    J Rheumatol; 2020 Feb; 47(2):300. PubMed ID: 31787603
    [No Abstract]   [Full Text] [Related]  

  • 85. The microenvironment matters: estrogen deficiency fuels cancer bone metastases.
    Wright LE; Guise TA
    Clin Cancer Res; 2014 Jun; 20(11):2817-9. PubMed ID: 24803577
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cancer morbidity in rheumatoid arthritis: role of estrogen metabolites.
    Khan WA; Khan MW
    Biomed Res Int; 2013; 2013():748178. PubMed ID: 24151619
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bone remodeling in osteoporosis associated with rheumatoid arthritis.
    Kröger H; Arnala I; Alhava EM
    Calcif Tissue Int; 1991; 49 Suppl():S90. PubMed ID: 1933613
    [No Abstract]   [Full Text] [Related]  

  • 88. Frequency of infections among rheumatoid arthritis patients, before and after disease onset.
    Vandenbroucke JP; Kaaks R; Valkenburg HA; Boersma JW; Cats A; Festen JJ; Hartman AP; Huber-Bruning O; Rasker JJ; Weber J
    Arthritis Rheum; 1987 Jul; 30(7):810-3. PubMed ID: 3619963
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis.
    Zhang W; Gao R; Rong X; Zhu S; Cui Y; Liu H; Li M
    Front Endocrinol (Lausanne); 2022; 13():965258. PubMed ID: 36147571
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Anti-Inflammatory, Phytoestrogenic, and Antioxidative Role of Labisia pumila in Prevention of Postmenopausal Osteoporosis.
    Nadia ME; Nazrun AS; Norazlina M; Isa NM; Norliza M; Ima Nirwana S
    Adv Pharmacol Sci; 2012; 2012():706905. PubMed ID: 22611381
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comment on Nagayama et al.: Low serum albumin concentration is associated with increased risk of osteoporosis in postmenopausal patients with rheumatoid arthritis.
    Yoshii I
    J Orthop Sci; 2023 May; 28(3):715-716. PubMed ID: 36914483
    [No Abstract]   [Full Text] [Related]  

  • 92. Osteoporosis in rheumatoid arthritis.
    Avioli LV
    Arthritis Rheum; 1987 Jul; 30(7):830-1. PubMed ID: 3619965
    [No Abstract]   [Full Text] [Related]  

  • 93. The osteoporosis of rheumatoid arthritis.
    Duncan H; Frost HM; Villanueva AR; Sigler JW
    Arthritis Rheum; 1965 Oct; 8(5):943-54. PubMed ID: 5863108
    [No Abstract]   [Full Text] [Related]  

  • 94. Pregnancy-related effects on postmenopausal osteoporosis.
    Sioka C
    Menopause; 2011 May; 18(5):590-1; author response 591. PubMed ID: 21487314
    [No Abstract]   [Full Text] [Related]  

  • 95. Comment on: "Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide".
    Bahat G; Ilhan B; Karan MA
    Drugs Aging; 2020 Mar; 37(3):237-238. PubMed ID: 32048236
    [No Abstract]   [Full Text] [Related]  

  • 96. Authors' Reply to Comment on "Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide".
    Raterman HG; Lems WF
    Drugs Aging; 2020 Mar; 37(3):239-240. PubMed ID: 32048235
    [No Abstract]   [Full Text] [Related]  

  • 97. Using Osteoporosis Therapies in Combination.
    McClung MR
    Curr Osteoporos Rep; 2017 Aug; 15(4):343-352. PubMed ID: 28667435
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
    Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
    J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
    Rifbjerg-Madsen S; Christensen AW; Christensen R; Hetland ML; Bliddal H; Kristensen LE; Danneskiold-Samsøe B; Amris K
    PLoS One; 2017; 12(7):e0180014. PubMed ID: 28686639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.